TAC and Fe3O4 were loaded into the PLGA NPs, while anti-VEGF antibody was afforded to functionalize the surface of PLGA NPs for specifically targeting cancers with overexpressed VEGF-A. The gene discussed is VEGFA; the disease is cancer.